Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

1. Agalliu, I.
2. Ortega, R.A.
3. Luciano, M.S.
4. Mirelman, A.
5. Pont-Sunyer, C.
6. Brockmann, K.
7. Vilas, D.
8. Tolosa, E.
9. Berg, D.
10. Warø, B.
11. Glickman, A.
12. Raymond, D.
13. Inzelberg, R.
14. Ruiz-Martinez, J.
15. Mondragon, E.
16. Friedman, E.
17. Hassin-Baer, S.
18. Alcalay, R.N.
19. Mejia-Santana, H.
20. Aasly, J.
21. Foroud, T.
22. Marder, K.
23. Giladi, N.
24. Bressman, S.
25. Saunders-Pullman, R.